Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 8 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Genotype Medicine & Life Sciences
Cytochrome P-450 CYP2D6 Medicine & Life Sciences
Genes Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences
Pharmacogenetics Medicine & Life Sciences
Single Nucleotide Polymorphism Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants 2009 2019

RNA Precursors
Messenger RNA
Protein Splicing
Paclitaxel
Pharmaceutical Preparations

Embedding Pharmacogenotyping in an Integrated Health System for the Underserved

Flockhart, D. A., Dexter, P. & Skaar, T.

National Institutes of Health

9/5/146/30/18

Project: Research projectResearch Project--Cooperative Agreements

Costs and Cost Analysis
Health
Precision Medicine
Vulnerable Populations
Economics

Regulation of drug metabolizing enzymes by miRNAs

Skaar, T.

National Institutes of Health

9/30/092/28/18

Project: Research projectResearch Project

Drug and Narcotic Control
MicroRNAs
Enzymes
Pharmaceutical Preparations
Liver

Publications 1989 2017

  • 6097 Citations
  • 38 h-Index
  • 143 Article
  • 1 Review article
Pragmatic Clinical Trials
Cholinesterase Inhibitors
Caregivers
Alzheimer Disease
Costs and Cost Analysis
2 Citations

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Hicks, J. K., Sangkuhl, K., Swen, J. J., Ellingrod, V. L., Müller, D. J., Shimoda, K., Bishop, J. R., Kharasch, E. D., Skaar, T. C., Gaedigk, A., Dunnenberger, H. M., Klein, T. E., Caudle, K. E. & Stingl, J. C. 2017 (Accepted/In press) In : Clinical Pharmacology and Therapeutics.

Research output: Research - peer-reviewArticle

Common genetic polymorphisms of adenosine A2A receptor do not influence response to regadenoson

Berlacher, M., Mastouri, R., Philips, S., Skaar, T. C. & Kreutz, R. P. Apr 1 2017 In : Pharmacogenomics. 18, 6, p. 523-529 7 p.

Research output: Research - peer-reviewArticle

Adenosine A2A Receptors
Genetic Polymorphisms
regadenoson
Perfusion Imaging
Hemodynamics

CYP2D6 drug-gene and drug-drug-gene interactions among patients prescribed pharmacogenetically actionable opioids

Knisely, M. R., Carpenter, J. S., Draucker, C. B., Skaar, T., Broome, M. E., Holmes, A. M. & Von Ah, D. Dec 1 2017 In : Applied Nursing Research. 38, p. 107-110 4 p.

Research output: Research - peer-reviewArticle

Cytochrome P-450 CYP2D6
Drug Interactions
Opioid Analgesics
Pharmaceutical Preparations
Genes

CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study

Hertz, D. L., Kidwell, K. M., Hilsenbeck, S. G., Oesterreich, S., Osborne, C. K., Philips, S., Chenault, C., Hartmaier, R. J., Skaar, T. C., Sikora, M. J. & Rae, J. M. Nov 1 2017 In : Breast Cancer Research and Treatment. 166, 1, p. 277-287 11 p.

Research output: Research - peer-reviewArticle

Cytochrome P-450 CYP2D6
Tamoxifen
Genotype
Breast Neoplasms
Survival